Overview

RESTORE Imaging: an OCT-IVUS Imaging Substudy of RESTORE Trial

Status:
RECRUITING
Trial end date:
2026-06-01
Target enrollment:
Participant gender:
Summary
The objective of this imaging substudy of RESTORE trial is to demonstrate the superiority of drug-coated balloon (DCB) treatment on non-flow limited vulnerable plaque as compared to guideline-directed medical therapy (GDMT) in improving plaque stabilization in patients with acute coronary syndrome.
Phase:
NA
Details
Lead Sponsor:
Harbin Medical University
Collaborator:
Shanghai Shenqi Medical Technology Co., Ltd